Tel:+086-0556-5800026 中文版|English

Antineoplastic Medicine
Antineoplastic Medicine You are here:首页>>HAIKANG PHARMACEUTICAL>>Products>>Antineoplastic Medicine
Imatinib mesylate 220127-57-1 | 甲磺酸伊马替尼 | API Supplier - Anhui Haikang
2019-09-02 07:35:52 2692 go back

Imatinib mesylate 220127-57-1 English Name Imatinib mesylate Chinese Name 甲磺酸伊马替尼 CAS No. 220127-57-1 Product Type API Product Overview Imatinib mesylate (CAS 220127-57-1, 甲磺酸伊马替尼) is offered by Anhui Haikang Pharmaceutical Co., Ltd. as an API for pharmaceutical R&D, process development and qualified commercial sourcing. The product belongs to our oncology pharmaceutical portfolio and can be supplied with specification discussion, COA support and packaging arranged according to customer requirements. Applications Suitable for compliant pharmaceutical sourcing discussions, process verification, analytical reference, formulation development support and commercial supply evaluation where permitted by applicable regulations. Supply & Documentation Available information may include COA, specification, impurity profile discussion, batch availability, lead time, packaging option and shipment documentation. Exact supply status and documentation should be confirmed before order placement. Packaging Packaging can be arranged according to product properties, quantity and customer requirements. Common options may include sealed bags, bottles, drums or other agreed export-ready packaging. Inquiry For Imatinib mesylate CAS 220127-57-1 quotation, COA, specification and availability, contact Anhui Haikang Pharmaceutical at wangyu@hkpharm.cn or +86 17709662922.